These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27155495)

  • 1. Development of a stable liquid formulation of live attenuated influenza vaccine.
    White JA; Estrada M; Flood EA; Mahmood K; Dhere R; Chen D
    Vaccine; 2016 Jul; 34(32):3676-83. PubMed ID: 27155495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a Stable Liquid Formulation for Live Attenuated Influenza Vaccine.
    Sun Y; Shen Z; Zhang C; Yi Y; Zhu K; Xu F; Kong W
    J Pharm Sci; 2019 Jul; 108(7):2315-2322. PubMed ID: 30826350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stabilization of Live Attenuated Influenza Vaccines by Freeze Drying, Spray Drying, and Foam Drying.
    Lovalenti PM; Anderl J; Yee L; Nguyen V; Ghavami B; Ohtake S; Saxena A; Voss T; Truong-Le V
    Pharm Res; 2016 May; 33(5):1144-60. PubMed ID: 26818839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of cell culture (MDCK) derived live attenuated influenza vaccine (LAIV) in a fully disposable platform process.
    George M; Farooq M; Dang T; Cortes B; Liu J; Maranga L
    Biotechnol Bioeng; 2010 Aug; 106(6):906-17. PubMed ID: 20589670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity in man of a cell culture derived trivalent live attenuated seasonal influenza vaccine: a Phase I dose escalating study in healthy volunteers.
    Heldens J; Hulskotte E; Voeten T; Breedveld B; Verweij P; van Duijnhoven W; Rudenko L; van Damme P; van den Bosch H
    Vaccine; 2014 Sep; 32(39):5118-24. PubMed ID: 24858566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on Stability II: stability of a vaccine.
    Abdul-Fattah AM; Truong-Le V; Yee L; Pan E; Ao Y; Kalonia DS; Pikal MJ
    Pharm Res; 2007 Apr; 24(4):715-27. PubMed ID: 17372697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of neuraminidase in inactivated influenza vaccines.
    Sultana I; Yang K; Getie-Kebtie M; Couzens L; Markoff L; Alterman M; Eichelberger MC
    Vaccine; 2014 Apr; 32(19):2225-30. PubMed ID: 24613525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a Freeze-Dried, Heat-Stable Influenza Subunit Vaccine Formulation.
    Flood A; Estrada M; McAdams D; Ji Y; Chen D
    PLoS One; 2016; 11(11):e0164692. PubMed ID: 27851765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of protective immunity against H1N1 influenza A(H1N1)pdm09 with spray-dried and electron-beam sterilised vaccines in non-human primates.
    Scherließ R; Ajmera A; Dennis M; Carroll MW; Altrichter J; Silman NJ; Scholz M; Kemter K; Marriott AC
    Vaccine; 2014 Apr; 32(19):2231-40. PubMed ID: 24631078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective efficacy in mice of monovalent and trivalent live attenuated influenza vaccines in the background of cold-adapted A/X-31 and B/Lee/40 donor strains.
    Jang YH; Lee EY; Byun YH; Jung EJ; Lee YJ; Lee YH; Lee KH; Lee J; Seong BL
    Vaccine; 2014 Jan; 32(5):535-43. PubMed ID: 24342248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined semi-empirical screening and design of experiments (DOE) approach to identify candidate formulations of a lyophilized live attenuated tetravalent viral vaccine candidate.
    Patel A; Erb SM; Strange L; Shukla RS; Kumru OS; Smith L; Nelson P; Joshi SB; Livengood JA; Volkin DB
    Vaccine; 2018 May; 36(22):3169-3179. PubMed ID: 28506515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term stability of influenza vaccine in a dissolving microneedle patch.
    Mistilis MJ; Joyce JC; Esser ES; Skountzou I; Compans RW; Bommarius AS; Prausnitz MR
    Drug Deliv Transl Res; 2017 Apr; 7(2):195-205. PubMed ID: 26926241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of Live Attenuated Influenza Virus by Using Codon Usage Bias.
    Fan RL; Valkenburg SA; Wong CK; Li OT; Nicholls JM; Rabadan R; Peiris JS; Poon LL
    J Virol; 2015 Nov; 89(21):10762-73. PubMed ID: 26269186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dry Formulations Enhanced Mucoadhesive Properties and Reduced Cold Chain Handing of Influenza Vaccines.
    Saengkrit N; Saesoo S; Woramongkolchai N; Sajomsang W; Phunpee S; Dharakul T; Ruktanonchai UR
    AAPS PharmSciTech; 2018 Nov; 19(8):3763-3769. PubMed ID: 30259401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of monophosphoryl lipid A as adjuvant for pulmonary delivered influenza vaccine.
    Patil HP; Murugappan S; ter Veer W; Meijerhof T; de Haan A; Frijlink HW; Wilschut J; Hinrichs WL; Huckriede A
    J Control Release; 2014 Jan; 174():51-62. PubMed ID: 24269505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Live attenuated influenza A virus vaccine protects against A(H1N1)pdm09 heterologous challenge without vaccine associated enhanced respiratory disease.
    Gauger PC; Loving CL; Khurana S; Lorusso A; Perez DR; Kehrli ME; Roth JA; Golding H; Vincent AL
    Virology; 2014 Dec; 471-473():93-104. PubMed ID: 25461535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation development of a plant-derived H1N1 influenza vaccine containing purified recombinant hemagglutinin antigen.
    Iyer V; Liyanage MR; Shoji Y; Chichester JA; Jones RM; Yusibov V; Joshi SB; Middaugh CR
    Hum Vaccin Immunother; 2012 Apr; 8(4):453-64. PubMed ID: 22370514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stabilization of HAC1 influenza vaccine by spray drying: formulation development and process scale-up.
    Zhu C; Shoji Y; McCray S; Burke M; Hartman CE; Chichester JA; Breit J; Yusibov V; Chen D; Lal M
    Pharm Res; 2014 Nov; 31(11):3006-18. PubMed ID: 24858396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.
    Fiore AE; Uyeki TM; Broder K; Finelli L; Euler GL; Singleton JA; Iskander JK; Wortley PM; Shay DK; Bresee JS; Cox NJ;
    MMWR Recomm Rep; 2010 Aug; 59(RR-8):1-62. PubMed ID: 20689501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immune protective effectiveness of seasonal influenza spilt vaccine against homologous and heterogonous subtypes of influenza virus in mice].
    Huang BY; Wang XP; Wang WL; Hu W; Gao Q; Tan WJ; Ruan L
    Bing Du Xue Bao; 2011 May; 27(3):265-73. PubMed ID: 21774253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.